Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 1.3B | 1.3B | 1.3B | 1.2B |
Cost of revenue | 492M | 478M | 485M | 462M |
Gross profit | 814M | 820M | 802M | 755M |
Operating expense | ||||
Research & development | 250M | 249M | 233M | 226M |
Selling general and admin | 360M | 361M | 343M | 329M |
Other operating expenses | -3M | -8M | -4M | -5M |
Operating income | 207M | 218M | 230M | 205M |
Non operating interest income | ||||
Income | 21M | 19M | 21M | 19M |
Expense | 20M | 20M | 23M | 21M |
Other income expense | 112M | -18M | 20M | 10M |
Pretax income | 320M | 199M | 248M | 213M |
Tax provision | 63M | 30M | 321M | -176M |
Net income | 257M | 169M | -73M | 389M |
Basic EPS | 1.5 | 1.0 | -0.4 | 2.2 |
Diluted EPS | 1.5 | 1.0 | -0.4 | 2.2 |
Basic average shares | 172M | 173M | 173M | 174M |
Diluted average shares | 173M | 174M | 173M | 175M |
EBITDA | 408M | 285M | 339M | 298M |
Net income from continuing op. | 257M | 169M | -73M | 389M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |